Health Bulletin 3/October/2022 Roshni Dhar3 Oct 2022 5:24 PM ISTHere are the top health news for the day:NMC seeks report on suicides by medicos, directs institutes to submit data Taking cognizance of the...
Kerala HC directs Health Ministry, DoP to reply on unaffordability of patented cancer drug Ribociclib Farhat Nasim2 Oct 2022 4:00 PM ISTThiruvananthapuram: The Kerala High Court has directed the Department of Pharmaceuticals (DoP) and a competent officer of Union Health Ministry to...
New device discovered by scientists to measure changing size of tumors below skin Roshni Dhar18 Sept 2022 3:51 PM ISTEngineers at the Georgia Institute of Technology and Stanford University have developed a small, self-contained device with a...
Trademark Infringement: Delhi HC rejects Sun Pharma plea against Hetero over cancer drug Letroz Roshni Dhar9 Sept 2022 3:43 PM ISTHolding that when the name is derived or coined from the name of the principal ingredient being used in the manufacture of the drug, no...
Health Bulletin 8/September/2022 Roshni Dhar8 Sept 2022 5:34 PM ISTHere are the top health news for the day:MCC NEET PG 2022 counselling tentative schedule released, check out detailsThe Medical Counselling Committee...
Dr Reddy's Labs unveils cancer drug Lenalidomide in US Ruchika Sharma8 Sept 2022 2:47 PM ISTDr. Reddy's Lenalidomide Capsules are available in strengths of 2.5 mg, 5 mg, and 10 mg, each in a bottle-count size of 28, as well as 15 mg, 20 mg,...
Cipla Cancer drug Lenalidomide bags USFDA okay Ruchika Sharma7 Sept 2022 4:22 PM ISTMumbai: Drugmaker, Cipla Limited, today announced that the company has received final approval for its Abbreviated New Drug Application (ANDA) for...
Setback: HC rejects Sun Pharma plea against Hetero alleging trademark infringement of cancer drug Letroz Farhat Nasim6 Sept 2022 5:33 PM ISTNew Delhi: Holding that when the name is derived or coined from the name of the principal ingredient being used in the manufacture of the drug, no...
Temozolomide safe in patients with renal dysfunction, study claims Jacinthlyn Sylvia29 Aug 2022 7:45 PM ISTUSA: Patients with severe renal impairment, defined as an eGFR < 36 mL/min/1.73m2, experience hematologic toxicity comparable to that of patients...
Health Bulletin 23/August/2022 Roshni Dhar23 Aug 2022 5:18 PM ISTHere are the top health news for the day:'Tomato fever' misleading colloquial name for hand, foot and mouth disease Medical professional has informed...
AstraZeneca India breast cancer drug lynparza gets DCGI okay Isra Zaman22 Aug 2022 5:15 PM ISTAstraZeneca India, a science-led biopharmaceutical company, has announced that it has received a Drugs Controller General of India (DCGI) approval to...
Sanofi halts breast cancer drug Amcenestrant clinical development program Ruchika Sharma18 Aug 2022 1:15 PM ISTParis: Pharma major, Sanofi, has announced the discontinuation of the global clinical development program of amcenestrant, an investigational oral...
